A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Academic Article uri icon

Overview

publication date

  • May 1, 1995

Research

keywords

  • Adenoviridae
  • Clinical Trials, Phase I as Topic
  • Cystic Fibrosis
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Gene Transfer Techniques
  • Genetic Therapy

Identity

Scopus Document Identifier

  • 0029102198

Digital Object Identifier (DOI)

  • 10.1089/hum.1995.6.5-643

PubMed ID

  • 7578401

Additional Document Info

volume

  • 6

issue

  • 5